BANK OF AMERICA CORP /DE/ - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,145,317
-30.1%
168,657
-22.6%
0.00%
Q2 2023$3,067,172
-40.5%
217,839
-34.8%
0.00%
-100.0%
Q1 2023$5,158,339
+10.8%
333,873
+17.5%
0.00%0.0%
Q4 2022$4,656,269
+41.8%
284,092
+60.0%
0.00%
Q3 2022$3,284,000
+43.1%
177,523
+1.7%
0.00%
Q2 2022$2,295,000
-45.5%
174,552
-61.6%
0.00%
Q1 2022$4,208,000
-85.8%
453,972
-85.0%
0.00%
-100.0%
Q4 2021$29,543,000
+4530.6%
3,023,963
+15986.6%
0.00%
Q3 2021$638,000
-1.4%
18,798
+6.3%
0.00%
Q2 2021$647,000
-9.0%
17,682
+11.5%
0.00%
Q1 2021$711,000
-42.3%
15,854
-26.5%
0.00%
Q4 2020$1,232,000
+55.8%
21,584
+40.1%
0.00%
Q3 2020$791,000
-39.5%
15,404
-29.6%
0.00%
Q2 2020$1,307,000
+8.9%
21,892
-24.9%
0.00%
Q1 2020$1,200,000
-87.0%
29,142
-80.3%
0.00%
-100.0%
Q4 2019$9,211,000
+1983.9%
147,976
+1036.5%
0.00%
Q3 2019$442,000
-24.8%
13,020
-50.0%
0.00%
Q2 2019$588,000
+1.4%
26,052
+4.2%
0.00%
Q1 2019$580,000
+17.4%
24,990
+6.1%
0.00%
Q4 2018$494,000
+766.7%
23,561
+1506.1%
0.00%
Q3 2018$57,000
-44.7%
1,467
-43.8%
0.00%
Q2 2018$103,000
+758.3%
2,609
+316.1%
0.00%
Q1 2018$12,000
-50.0%
627
-40.5%
0.00%
Q4 2017$24,0001,0530.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders